People
-
Texas-based Pulmotect, which is developing an inhaled immune stimulant for the treatment of respiratory diseases, has announced the appointment of Colin Broom as CEO. Broom was most recently CEO of Nabriva Therapeutics and previously served… Read more . . .
-
Inhalation Sciences AB (ISAB) has announced that former ExScale Bio CEO Manoush Masarrat, who has been a member of the ISAB board of directors since January 2019, will succeed Lena Heffler as ISAB CEO. In… Read more . . .
-
Milestone Pharmaceuticals has announced the appointment of former Sanofi executive Amit Hasija as Chief Financial Officer and Executive VP of Corporate Development. Milestone’s etripamil, an intranasal calcium channel antagonist, is in Phase 3 development for the treatment… Read more . . .
-
CDMO Experic has announced the appointment of Denise Sabaday as vice president of business development. Sabaday was most recently Executive VP of Business Development and Marketing at Transformative Pharmaceutical Solutions and was previously Director of Business… Read more . . .
-
Pneuma Respiratory, which is developing a digital soft mist inhaler, has announced the appointment of Jay Morgan as Chairman of the Board. Morgan, a former Bayer and Merck executive who has been a member of the board… Read more . . .
-
Circassia Pharmaceuticals has announced the appointment of Jonathan Emms as Chief Operating Officer and as an Executive Director of the Board of Directors. Emms previously served in a number of executive roles at Pfizer, most… Read more . . .
-
Proveris Scientific has announced an expansion of its Americas and Asia Pacific customer service support team with the hire of Doug Mann as a Field Service Engineer. The company also recently added Stephen McDonald to… Read more . . .
-
AZTherapies has announced that former Dooner Laboratories and Muro Pharmaceuticals CEO George D. Behrakis has joined the company’s board of directors. Behrakis sold Dooner Laboratories, which manufactured theophylline products for asthma, to Rorer in 1977… Read more . . .
-
AZTherapies, which is developing an inhaled cromolyn sodium/ibuprofen formulation, has named Jay Mohr as Chief Operating Officer, Chief Business Officer, and Head of Commercial Development. Mohr was most recently co-founder and Managing Director of Locust… Read more . . .
-
Members of the OINDP community are remembering inhalation expert Ola Nerbrink, who passed away on June 1, 2019. He was the CEO of Respiron Consulting, which he founded in 2009, and VP of Business Development… Read more . . .
Featured event:

Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK



